| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $312.8M | — | +111.1% |
| SG&A Expense | $33.1M | — | +1.3% |
| Operating Income | -$345.9M | — | -91.3% |
| Income Tax | $0 | — | — |
| Net Income | -$320.6M | — | -127.8% |
| EPS (Basic) | -$2.30 | — | -121.2% |
| EPS (Diluted) | -$2.30 | — | -121.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $260.8M | +49.9% | -24.8% |
| Short-term Investments | $1.48B | +6.4% | +11.4% |
| Current Assets | $1.81B | +11.4% | +5.6% |
| Total Assets | $3.35B | +11.5% | -0.9% |
| Current Liabilities | $242.1M | +17.7% | +149.6% |
| Total Liabilities | $352.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$280.6M | — | -68.8% |
| Capital Expenditures | $2.1M | — | -61.2% |
| Investing Cash Flow | -$233.4M | — | -289.3% |
| Financing Cash Flow | $601.6M | — | — |
| Free Cash Flow | -$282.7M | — | -64.7% |
| +97.8% |
| Stockholders' Equity | $3.00B | +11.6% | -6.4% |